Morpho-molecular identification of causing anthracnose disease of banana in Pakistan.

Banana (Musa spp.) is widely cultivated as the major fruit in Pakistan. Anthracnose fruit rot caused by various Colletotrichum spp.

Exosomal Dynamics: Bridging the Gap Between Cellular Senescence and Cancer Therapy.

Cancer remains one of the most devastating diseases, severely affecting public health and contributing to economic instability. Researchers worldwide are dedicated to developing effective therapeutics to target cancer cells. One promising strategy involves inducing cellular senescence, a complex state in which cells exit the cell cycle.

Threats across boundaries: the spread of ESBL-positive bacteria and its challenge to the "one health" concept.

-lactam antibiotics are essential medications for treating human diseases. The spread of extended-spectrum β-lactamase-producing (ESBL-PE) exists globally in multiple reservoirs and the natural environment and poses an immense threat to public health. Plasmid incompatibility groups, such as IncFIA, IncI1, IncY, IncFIB, IncN, IncFIC, IncX4, IncB/O/K/Z, IncHI1/2, and IncA/C, which exist in humans, animals, and the environment, carrying , , and genes.

Impact of urea-molasses treated wheat straw levels in total mixed rations on growth and nutrient digestibility in Azikheli buffalo calves.

This study investigates the impact of urea molasses-treated wheat straw on growth performance and nutrient digestibility in Azikheli buffalo male calves. A longitudinal experiment was conducted on sixteen calves, randomly assigned to four experimental dietary treatments (n = 4 per group). The experimental diets included a control group (U0) with untreated wheat straw and three groups where urea molasses-treated wheat straw replaced 33% (U33), 66% (U66), or 100% (U100) of the straw in the total mixed ration.

Identification and Treatment of Intravascular Hypervolemia and Polycythemia in Patients With Heart Failure: Role of Therapeutic Phlebotomy.

Intravascular hypervolemia with polycythemia is a blood volume phenotype in patients with heart failure that portends additional risks including thrombotic events. This paper presents 4 patients with heart failure with this blood volume phenotype and focuses on its identification and the role of therapeutic phlebotomy including patient selection and outcomes.